An increased level of IGFBP-2 in serum correlates with the presence of neoplastic alterations in the colon and concentrations of carcinoembryonic antigen (CEA) in colon cancer patients [188,189]. The gene discussed is CEACAM5; the disease is colonic neoplasm.